Inflammatory Bowel Diseases
Immunology·MeSH: Inflammatory Bowel Diseases
Prevalence
50.7 / 100K
Incidence
5.0 / 100K/yr
3 drugs in development·3 companies·14 clinical trials
Drug Pipeline by Phase
Phase 2(2)
Preclinical(1)
| Drug | Company |
|---|---|
| ht-003 | Hoth Therapeutics, Inc. (HOTH) |
Compare drugs
Frequently asked questions
How many drugs are in development for Inflammatory Bowel Diseases?
BioSniper tracks 3 drugs in development for Inflammatory Bowel Diseases across 3 companies.
How many clinical trials target Inflammatory Bowel Diseases?
There are 14 clinical trials targeting Inflammatory Bowel Diseases tracked by BioSniper.
What is the prevalence of Inflammatory Bowel Diseases?
The estimated prevalence of Inflammatory Bowel Diseases is approximately 50.7 per 100,000 population.
Deep-dive into Inflammatory Bowel Diseases
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis